XML 43 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Valuation of our financial instruments by pricing observability levels as of March 31, 2020 and December 31, 2019 was as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
 
NAV Expedient(1)
 
Other
 
Total
March 31, 2020:
 
 
 
 
 
 
 
 
 
 
 
Money markets
$
123,767

 
$

 
$

 
$

 
$

 
$
123,767

Securities segregated (U.S. Treasury Bills)

 
2,012,198

 

 

 

 
2,012,198

Derivatives
1,505

 
31,061

 

 

 

 
32,566

Investments
 
 
 
 
 
 
 
 
 
 
 
  Equity securities
136,573

 
17,589

 
118

 
159

 

 
154,439

Long exchange-traded options
36,783

 

 

 

 

 
36,783

   Limited partnership hedge funds(2)

 

 

 

 
42,393

 
42,393

   Time deposits(3)

 

 

 

 
17,303

 
17,303

   Other investments
4,637

 

 

 

 
6,953

 
11,590

Total investments
177,993

 
17,589

 
118

 
159

 
66,649

 
262,508

Total assets measured at fair value
$
303,265

 
$
2,060,848

 
$
118

 
$
159

 
$
66,649

 
$
2,431,039

 
 
 
 
 
 
 
 
 
 
 
 
Securities sold not yet purchased
 

 
 

 
 

 
 
 
 
 
 

Short equities – corporate
$
11,745

 
$

 
$

 
$

 
$

 
$
11,745

Short exchange-traded options
15,884

 

 

 

 

 
15,884

Derivatives
4,895

 
35,161

 

 

 

 
40,056

Contingent payment arrangements

 

 
23,704

 

 

 
23,704

Total liabilities measured at fair value
$
32,524

 
$
35,161

 
$
23,704

 
$

 
$

 
$
91,389

 
 
 
 
 
 
 
 
 
 
 
 

 
Level 1
 
Level 2
 
Level 3
 
NAV Expedient(1)
 
Other
 
Total
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
Money markets
$
126,401

 
$

 
$

 
$

 
$

 
$
126,401

Securities segregated (U.S. Treasury Bills)

 
1,094,866

 

 

 

 
1,094,866

Derivatives
939

 
12,552

 

 

 

 
13,491

Investments
 
 
 
 
 
 
 
 
 
 
 
  Equity securities
170,946

 
8,952

 
119

 
314

 

 
180,331

  Long exchange-traded options
6,931

 

 

 

 

 
6,931

    Limited partnership hedge funds(2)

 

 

 

 
47,361

 
47,361

    Time deposits(3)

 

 

 

 
18,281

 
18,281

    Other investments
5,883

 

 

 

 
8,007

 
13,890

Total investments
183,760

 
8,952

 
119

 
314

 
73,649

 
266,794

Total assets measured at fair value
$
311,100

 
$
1,116,370

 
$
119

 
$
314

 
$
73,649

 
$
1,501,552

 
 
 
 
 
 
 
 
 
 
 
 
Securities sold not yet purchased
 

 
 

 
 

 
 
 
 
 
 

Short equities – corporate
$
17,809

 
$

 
$

 
$

 
$

 
$
17,809

Short exchange-traded options
12,348

 

 

 

 

 
12,348

Derivatives
871

 
18,388

 

 

 

 
19,259

Contingent payment arrangements

 

 
22,911

 

 

 
22,911

Total liabilities measured at fair value
$
31,028


$
18,388


$
22,911


$

 
$

 
$
72,327



(1) Investments measured at fair value using NAV (or its equivalent) as a practical expedient.
(2) Investments in equity method investees that are not measured at fair value in accordance with GAAP.
(3) Investments carried at amortized cost that are not measured at fair value in accordance with GAAP.
Schedule of Change in Carrying Value Level 3 Financial Instruments
The change in carrying value associated with Level 3 financial instruments carried at fair value, classified as private equity and equity securities, is as follows:
 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in thousands)
Balance as of beginning of period
 
$
119

 
$
142

Purchases
 

 

Sales
 

 

Realized gains (losses), net
 

 

Unrealized gains (losses), net
 
(1
)
 
(27
)
Balance as of end of period
 
$
118

 
$
115


Schedule of Contingent Payment Arrangements Level 3 Financial Instruments The change in carrying value associated with Level 3 financial instruments carried at fair value, classified as contingent payment arrangements, is as follows:
 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in thousands)
Balance as of beginning of period
 
$
22,911

 
$
7,336

Addition
 

 

Accretion
 
793

 
54

Payments
 

 

Balance as of end of period
 
$
23,704

 
$
7,390